Top Markets
#1 Pleasing Gold Pleasing Gold +1,501.62%
#2 Ontology Gas Ontology Gas +182.29%
#3 PulseChain PulseChain +57.88%
#4 Ontology Ontology +40.20%
#5 ConstitutionDAO ConstitutionDAO +36.86%
#6 Osmosis Osmosis +36.34%
#7 BOOK OF MEME BOOK OF MEME +31.61%
#8 Collect on Fanable Collect on Fanable +26.31%
#9 Neiro Neiro +25.71%
#10 Pump.fun Pump.fun +24.19%
Coin of the day
Pleasing Gold Pleasing Gold
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Icosavax, Inc. Icosavax, Inc.

Icosavax, Inc.

ICVX
Pozycja w akcjach #25854
Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing... Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing immunizations against infectious diseases. Leveraging its proprietary virus-like particle (VLP) platform technology, the company primarily focuses its efforts on severe respiratory illnesses. Its developmental portfolio includes several key vaccine candidates: IVX-121, an RSV-targeted vaccine currently undergoing Phase 1/1b clinical trials; IVX-A12, a bivalent candidate designed to target both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV); IVX-241, a candidate specifically designed for hMPV; and IVX-411, a SARS-CoV-2 vaccine based on a receptor binding domain (RBD) sequence antigen, which is also in Phase 1/2 clinical trials. Established in 2017, Icosavax maintains its corporate headquarters in Seattle, Washington.
Cena akcji
$15.31
Ostatnia synchronizacja: 2024-02-29
Kapitalizacja rynkowa
$45.70M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Icosavax, Inc. (ICVX)

Kategoria

Healthcare
Zyski dla Icosavax, Inc. (ICVX)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Icosavax, Inc., obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Icosavax, Inc. od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US